Investment House LLC Has $5.03 Million Stake in Solventum Co. (NYSE:SOLV)

Investment House LLC increased its stake in shares of Solventum Co. (NYSE:SOLV) by 111.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 76,171 shares of the company’s stock after purchasing an additional 40,130 shares during the quarter. Investment House LLC’s holdings in Solventum were worth $5,032,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Modus Advisors LLC bought a new stake in shares of Solventum during the fourth quarter valued at approximately $25,000. Stonebridge Financial Group LLC bought a new stake in shares of Solventum during the fourth quarter valued at approximately $26,000. True Wealth Design LLC grew its stake in shares of Solventum by 23,550.0% during the third quarter. True Wealth Design LLC now owns 473 shares of the company’s stock valued at $33,000 after purchasing an additional 471 shares during the last quarter. Crews Bank & Trust bought a new stake in shares of Solventum during the fourth quarter valued at approximately $32,000. Finally, Prospera Private Wealth LLC bought a new stake in shares of Solventum during the third quarter valued at approximately $35,000.

Analyst Ratings Changes

SOLV has been the topic of several research analyst reports. Piper Sandler increased their price target on shares of Solventum from $75.00 to $84.00 and gave the company a “neutral” rating in a research note on Friday, February 28th. The Goldman Sachs Group raised their price objective on shares of Solventum from $63.00 to $71.00 and gave the company a “sell” rating in a research note on Monday, March 3rd. Wells Fargo & Company raised their price objective on shares of Solventum from $73.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, February 28th. Bank of America raised their price objective on shares of Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a research note on Wednesday, February 26th. Finally, Mizuho raised their price objective on shares of Solventum from $70.00 to $82.00 and gave the company a “neutral” rating in a research note on Monday, March 3rd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat, Solventum currently has a consensus rating of “Hold” and an average price target of $79.86.

Solventum Price Performance

Shares of SOLV stock opened at $75.38 on Wednesday. Solventum Co. has a 12-month low of $47.16 and a 12-month high of $85.92. The firm has a market capitalization of $13.04 billion and a price-to-earnings ratio of 27.41. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The firm has a fifty day moving average of $74.77 and a 200-day moving average of $71.38.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.